These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 28019652)

  • 1. Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels.
    Witkiewitz K; Hallgren KA; Kranzler HR; Mann KF; Hasin DS; Falk DE; Litten RZ; O'Malley SS; Anton RF
    Alcohol Clin Exp Res; 2017 Jan; 41(1):179-186. PubMed ID: 28019652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial.
    Witkiewitz K; Falk DE; Litten RZ; Hasin DS; Kranzler HR; Mann KF; O'Malley SS; Anton RF
    Alcohol Clin Exp Res; 2019 May; 43(5):979-987. PubMed ID: 30951210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization risk drinking level reductions are associated with improved functioning and are sustained among patients with mild, moderate and severe alcohol dependence in clinical trials in the United States and United Kingdom.
    Witkiewitz K; Heather N; Falk DE; Litten RZ; Hasin DS; Kranzler HR; Mann KF; O'Malley SS; Anton RF
    Addiction; 2020 Sep; 115(9):1668-1680. PubMed ID: 32056311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.
    Witkiewitz K; Kranzler HR; Hallgren KA; O'Malley SS; Falk DE; Litten RZ; Hasin DS; Mann KF; Anton RF
    Alcohol Clin Exp Res; 2018 Dec; 42(12):2453-2465. PubMed ID: 30395350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Posttreatment Reductions in World Health Organization (WHO) Drinking Risk Levels and Posttreatment Functioning in Older Adults with DSM-5 Alcohol Use Disorder: Secondary Data Analysis of the Elderly Study.
    Mejldal A; Andersen K; Behrendt S; Bilberg R; Bogenschutz M; Braun-Michl B; Bühringer G; Søgaard Nielsen A
    Alcohol Clin Exp Res; 2021 Mar; 45(3):638-649. PubMed ID: 33496964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Drinking Reductions and Long-term Functioning Among Patients with Alcohol Use Disorder.
    Witkiewitz K; Kranzler HR; Hallgren KA; Hasin DS; Aldridge AP; Zarkin GA; Mann KF; O'Malley SS; Anton RF
    J Gen Intern Med; 2021 Feb; 36(2):404-412. PubMed ID: 33180306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?
    Mann K; Aubin HJ; Witkiewitz K
    Eur Addict Res; 2017; 23(5):219-230. PubMed ID: 28934736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reductions in World Health Organization risk drinking level are associated with improvements in sleep problems among individuals with alcohol use disorder.
    Garcia CC; Richards DK; Tuchman FR; Hallgren KA; Kranzler HR; Aubin HJ; O'Malley SS; Mann K; Aldridge A; Hoffman M; Anton RF; Witkiewitz K
    Alcohol Alcohol; 2024 Mar; 59(3):. PubMed ID: 38606931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population.
    Knox J; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Scodes J; Anton R; Hasin DS;
    Alcohol Clin Exp Res; 2018 Nov; 42(11):2256-2265. PubMed ID: 30204248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cost Effectiveness of Nalmefene for Reduction of Alcohol Consumption in Alcohol-Dependent Patients with High or Very High Drinking-Risk Levels from a UK Societal Perspective.
    Brodtkorb TH; Bell M; Irving AH; Laramée P
    CNS Drugs; 2016 Feb; 30(2):163-77. PubMed ID: 26879458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Health Organization (WHO) risk level reductions in inpatients with alcohol use disorder and comorbid anxiety disorders.
    Stevenson BL; Anker J; Thuras P; Rinehart L; Kushner MG
    Psychol Addict Behav; 2023 Aug; 37(5):713-722. PubMed ID: 36480397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence: analysis of demographic, behavioral, physiologic, and drinking variables that contribute to dependence and seeking treatment. International Society on Biomedical Research on Alcoholism.
    Glanz J; Grant B; Monteiro M; Tabakoff B;
    Alcohol Clin Exp Res; 2002 Jul; 26(7):1047-61. PubMed ID: 12170115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Relationship Between Reductions in WHO Risk Drinking Levels During Treatment and Subsequent Healthcare Costs for the ACTIVE Workgroup.
    Aldridge AP; Zarkin GA; Dowd WN; Witkiewitz K; Hasin DS; O'Malley SS; Isenberg K; Anton RF
    J Addict Med; 2022 Jul-Aug 01; 16(4):425-432. PubMed ID: 34864785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol Consumption and Inpatient Health Service Utilization in a Cohort of Patients With Alcohol Dependence After 20 Years of Follow-up.
    Miquel L; Gual A; Vela E; Lligoña A; Bustins M; Colom J; Rehm J
    Alcohol Alcohol; 2017 Mar; 52(2):227-233. PubMed ID: 28182212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.
    Wallach JD; Gueorguieva R; Phan H; Witkiewitz K; Wu R; O'Malley SS
    Alcohol Clin Exp Res; 2022 Jul; 46(7):1331-1339. PubMed ID: 35616436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Benefits in reducing alcohol consumption: how nalmefene can help].
    Bendimerad P; Blecha L
    Encephale; 2014 Dec; 40(6):495-500. PubMed ID: 25454365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective follow-up of empirically derived Alcohol Dependence subtypes in wave 2 of the National Epidemiologic Survey on Alcohol And Related Conditions (NESARC): recovery status, alcohol use disorders and diagnostic criteria, alcohol consumption behavior, health status, and treatment seeking.
    Moss HB; Chen CM; Yi HY
    Alcohol Clin Exp Res; 2010 Jun; 34(6):1073-83. PubMed ID: 20374206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The World Health Organization Risk Drinking Levels Measure of Alcohol Consumption: Prevalence and Health Correlates in Nationally Representative Surveys of U.S. Adults, 2001-2002 and 2012-2013.
    Shmulewitz D; Aharonovich E; Witkiewitz K; Anton RF; Kranzler HR; Scodes J; Mann KF; Wall MM; Hasin D;
    Am J Psychiatry; 2021 Jun; 178(6):548-559. PubMed ID: 33472388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in non-abstinent World Health Organization (WHO) drinking risk levels and drug use disorders: 3-year follow-up results in the US general population.
    Knox J; Wall M; Witkiewitz K; Kranzler HR; Falk DE; Litten R; Mann K; O'Malley SS; Scodes J; Anton R; Hasin DS;
    Drug Alcohol Depend; 2019 Aug; 201():16-22. PubMed ID: 31174140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in non-abstinent WHO drinking risk levels and depression/anxiety disorders: 3-year follow-up results in the US general population.
    Knox J; Scodes J; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Anton R; Hasin DS;
    Drug Alcohol Depend; 2019 Apr; 197():228-235. PubMed ID: 30852375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.